Intravenous thromboembolism. Thromboembolism in the puerperium
Conditions
Interventions
Intervention 1: Intervention group: Administration of Rivarxaban 15 mg tablets once a day for 4 weeks after surgery from Dr. Obidi's factory. Intervention 2: Control group: Enoxaparin subcutaneous amp
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients undergoing spinal cord surgery Patient consent to participate in the study High risk of the patient for venous thromboembolism
Exclusion criteria
Exclusion criteria: Consumption of anticoagulants in the last 3 months Urine test with purpura-positive blood or cutaneous hematoma with active bleeding or high risk of bleeding Existence of active cancer as an underlying disease or cancer treated in the last 6 months Hospitalization and inactivity for more than 3 days Smoking more than 20 cigarettes a day Having a body mass index higher than 35 Pulmonary embolism and lower venous thrombosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intravenous Thromboembolism. Timepoint: In this study, hemorrhagic events caused by rivaroxaban and enoxaparin before surgery and 4 weeks after. Method of measurement: According to the patient's clinical symptoms. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Shafiei
Esfahan University of Medical Sciences
Outcome results
None listed